| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850700 | American Journal of Kidney Diseases | 2008 | 9 Pages |
Abstract
In this stable dialysis population, removal of β2M was more efficient with the Helixone super-flux FX-E membrane, with only a small decrease in albumin concentrations despite increased albumin loss. Large trials with longer treatment periods are required to evaluate the impact of the FX-E membrane on clinical outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Rebecca MBBS, FRACP, Kevan R. BHB, MClinEpi, MBChB, FRACP, PhD, Peter G. MBBS, PhD, FRACP,